0A88.LSE 10x Genomics, Inc.

Healthcare Medical Devices London Exchange
- USD
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0A88.LSE undervalued?

Graham number

The Graham number of 10x Genomics, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

10x Genomics, Inc. fundamental analysis

No fundamental analysis for 10x Genomics, Inc. yet.

10x Genomics, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About 10x Genomics, Inc.

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale sing…

Full company profile